Published in J Clin Pharmacol on September 01, 1997
Reexamining transaminase elevation in Phase I clinical trials: the importance of baseline and change from baseline. Eur J Clin Pharmacol (2009) 0.98
Bayesian adaptive designs in single ascending dose trials in healthy volunteers. Br J Clin Pharmacol (2014) 0.79
Designing and interpreting the results of first-time-to-man studies. Dialogues Clin Neurosci (2000) 0.75
A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther (1981) 69.83
Concern Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med (2000) 29.03
Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. Proc Natl Acad Sci U S A (1993) 9.47
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J (2001) 8.90
Drug therapy. Clinical Pharmacokinetics (first of two parts). N Engl J Med (1975) 7.60
Task shifting in HIV/AIDS: opportunities, challenges and proposed actions for sub-Saharan Africa. Trans R Soc Trop Med Hyg (2008) 6.39
Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell (2000) 5.23
Fetal growth and perinatal viability in California. Obstet Gynecol (1982) 5.23
Mefloquine (WR 142,490) in the treatment of human malaria. Science (1975) 5.20
Identifying the sources of the recent decline in perinatal mortality rates in California. N Engl J Med (1982) 4.64
Non-function of a Moloney murine leukaemia virus regulatory sequence in F9 embryonal carcinoma cells. Nature (1984) 4.52
Substandard medicines in resource-poor settings: a problem that can no longer be ignored. Trop Med Int Health (2008) 4.07
The first night effect: an EEG study of sleep. Psychophysiology (1966) 3.86
Outbreak of HIV infection in a Scottish prison. BMJ (1995) 3.82
Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis (2000) 3.81
Structural insights into phosphoinositide 3-kinase catalysis and signalling. Nature (1999) 3.81
Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma. Cell (2000) 3.68
Spatial and temporal expression of the Cre gene under the control of the MMTV-LTR in different lines of transgenic mice. Transgenic Res (2001) 3.45
Clinical pharmacokinetics (second of two parts). N Engl J Med (1975) 3.17
Use of benzodiazepines in anxiety disorders. N Engl J Med (1993) 3.12
Crystal structure of a mammalian phosphoinositide-specific phospholipase C delta. Nature (1996) 3.11
Identification of toxicants in cinnamon-flavored electronic cigarette refill fluids. Toxicol In Vitro (2014) 3.10
Drug therapy: drug disposition in old age. N Engl J Med (1982) 3.04
Cesarean section, fetal monitoring, and perinatal mortality in California. Am J Public Health (1979) 3.04
Pregnancy outcomes among Spanish-surname women in California. Am J Public Health (1986) 3.04
Effects of the antifungal agents on oxidative drug metabolism: clinical relevance. Clin Pharmacokinet (2000) 2.94
Midazolam: pharmacology and uses. Anesthesiology (1985) 2.89
Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science (1998) 2.83
Cesarean section in California--1960 through 1975. Am J Obstet Gynecol (1979) 2.81
Vancomycin therapy in patients with impaired renal function: a nomogram for dosage. Ann Intern Med (1981) 2.68
Offering integrated care for HIV/AIDS, diabetes and hypertension within chronic disease clinics in Cambodia. Bull World Health Organ (2007) 2.68
The influence of ethnicity and race on attitudes toward advance directives, life-prolonging treatments, and euthanasia. J Clin Ethics (1993) 2.66
Reducing black neonatal mortality. Will improvement in birth weight be enough? JAMA (1985) 2.56
Mice with a null mutation of the TGF alpha gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. Cell (1993) 2.52
Structure of HIV-1 reverse transcriptase/DNA complex at 7 A resolution showing active site locations. Nature (1992) 2.52
Single-dose kinetics of intravenous vancomycin. J Clin Pharmacol (1980) 2.48
The crystal structure of the PX domain from p40(phox) bound to phosphatidylinositol 3-phosphate. Mol Cell (2001) 2.47
Computer analysis of Staphylococcus aureus phage typing data from 1957 to 1975, citing epidemiological trends and natural evolution within the phage typing system. Appl Environ Microbiol (1980) 2.40
Family support and conflict: prospective relations to adolescent depression. J Abnorm Child Psychol (1997) 2.38
Gram-negative bacilli in burns. J Clin Pathol (1969) 2.35
Intramuscular injection of drugs. N Engl J Med (1976) 2.20
An elastic analysis of Listeria monocytogenes propulsion. Biophys J (2000) 2.19
Impairment of antipyrine clearance in humans by propranolol. Circulation (1978) 2.18
Diazepam disposition determinants. Clin Pharmacol Ther (1980) 2.16
Experimental infection of chickens as candidate sentinels for West Nile virus. Emerg Infect Dis (2001) 2.14
Effect of age, gender, and obesity on midazolam kinetics. Anesthesiology (1984) 2.14
Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? Am J Med (1976) 2.13
Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review. Clin Pharmacol Ther (2010) 2.13
Diagnostic marker cooperative study for the diagnosis of myocardial infarction. Circulation (1999) 2.09
Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis (2012) 2.09
Family processes in adolescent depression. Clin Child Fam Psychol Rev (2001) 2.07
Toxicity of high-dose flurazepam in the elderly. Clin Pharmacol Ther (1977) 2.05
Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QTc prolongation. Clin Pharmacol Ther (2001) 2.05
Preliminary, dermatologic first step criteria for lupus erythematosus and second step criteria for systemic lupus erythematosus. Int J Dermatol (1993) 2.05
Dose-related sleep disturbances induced by coffee and caffeine. Clin Pharmacol Ther (1976) 2.04
Suppression of leukaemia virus pathogenicity by polyoma virus enhancers. Nature (1985) 2.03
Rationale for tobacco cessation interventions for youth. Prev Med (1998) 2.01
Bias and 'overcall' in interpreting chest radiographs in young febrile children. Pediatrics (1992) 1.97
Is diazepam an antidepressant? Br J Psychiatry (1989) 1.96
Adult vitelliform macular detachment occurring in patients with basal laminar drusen. Am J Ophthalmol (1985) 1.96
Drug interaction studies: study design, data analysis, and implications for dosing and labeling. Clin Pharmacol Ther (2007) 1.90
CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants. Drug Metab Dispos (2000) 1.87
Inhibition of terfenadine metabolism in vitro by azole antifungal agents and by selective serotonin reuptake inhibitor antidepressants: relation to pharmacokinetic interactions in vivo. J Clin Psychopharmacol (1996) 1.86
Reduced benzodiazepine sensitivity in panic disorder. Arch Gen Psychiatry (1990) 1.84
Serotyping of Pseudomonas aeruginosa isolates from patients with cystic fibrosis of the pancreas. J Clin Microbiol (1975) 1.81
Development of myopia in infants with birth weights less than 1251 grams. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology (1992) 1.80
Automated gas chromatography for studies of midazolam pharmacokinetics. Anesthesiology (1981) 1.78
The trauma of war in Sierra Leone. Lancet (2000) 1.76
Crystal structure of a calcium-phospholipid binding domain from cytosolic phospholipase A2. J Biol Chem (1998) 1.75
Temporal variations in trough serum theophylline concentrations at steady state. J Pharm Sci (1980) 1.74
Recent outcomes in the treatment of burn injury in the United States: a report from the American Burn Association Patient Registry. J Burn Care Rehabil (1995) 1.74
Measurement of the elasticity of the actin tail of Listeria monocytogenes. Eur Biophys J (2000) 1.72
Ethnic differences in the relationships between obesity and glucose-metabolic abnormalities: a cross-sectional population-based study. Int J Obes (Lond) (2005) 1.72
Active transport of Na+ and Cl- across the canine tracheal epithelium in vitro. Am Rev Respir Dis (1975) 1.71
Monitoring perinatal mortality rates: California, 1970 to 1976. Am J Obstet Gynecol (1980) 1.70
Femoral nerve block in extracapsular femoral neck fractures. J Bone Joint Surg Br (1995) 1.70
Impact of pharmacometric reviews on new drug approval and labeling decisions--a survey of 31 new drug applications submitted between 2005 and 2006. Clin Pharmacol Ther (2007) 1.70
Disruption of the cytochrome c gene in xylose-utilizing yeast Pichia stipitis leads to higher ethanol production. Yeast (1999) 1.70
Empirical solvation models can be used to differentiate native from near-native conformations of bovine pancreatic trypsin inhibitor. Proteins (1991) 1.65
Toxicity of nitrazepam in the elderly: a report from the Boston Collaborative Drug Surveillance Program. Br J Clin Pharmacol (1978) 1.65
Measuring the effectiveness of perinatal medical care. Med Care (1979) 1.63
Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth. Am J Pathol (1999) 1.63
Isolation of embryonic stem (ES) cells in media supplemented with recombinant leukemia inhibitory factor (LIF). Dev Biol (1990) 1.61
Intrauterine growth curves: intra- and international comparisons with different ethnic groups in California. Prev Med (1975) 1.61
Clinical pharmacokinetics of quinidine. Clin Pharmacokinet (1980) 1.59
Benzodiazepines: a summary of pharmacokinetic properties. Br J Clin Pharmacol (1981) 1.59
Serological and genotypic diversity among serogroup 5- reacting environmental Legionella isolates. J Clin Microbiol (1982) 1.59
AIDS: patent rights versus patient's rights. Lancet (2000) 1.59
Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias. Circulation (1983) 1.57
Chiral colloidal clusters. Nature (2008) 1.57
Acute toxicity of cephaloridine, an antibiotic derived from cephalosporin C. Toxicol Appl Pharmacol (1966) 1.56
Viral hepatitis and the Global Burden of Disease: a need to regroup. J Viral Hepat (2013) 1.55
Adverse reactions to spironolactone. A report from the Boston Collaborative Drug Surveillance Program. JAMA (1973) 1.54
Adverse reactions to beta-adrenergic receptor blocking drugs: a report from the Boston collaborative drug surveillance program. Drugs (1974) 1.54
Nocturnal erections, differential diagnosis of impotence, and diabetes. Biol Psychiatry (1977) 1.54
The value of USP public standards for therapeutic products. Pharm Res (2004) 1.54
Dependence, tolerance, and addiction to benzodiazepines: clinical and pharmacokinetic considerations. Drug Metab Rev (1978) 1.54
Hoechst 33342 induces apoptosis in HL-60 cells and inhibits topoisomerase I in vivo. Arch Pathol Lab Med (1999) 1.53
Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma. J Clin Endocrinol Metab (1978) 1.53
Nm23/nucleoside diphosphate kinase: toward a structural and biochemical understanding of its biological functions. Bioessays (1995) 1.52